A Two-Week, Randomized, Double-Blind Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Pre-dose Versus Post-dose in Adult Subjects (=18 Years of Age) with Mild to Moderate Asthma, Receiving SYMBICORT pMDI 80/4.5 µg x 2 Actuations Twice Daily or Budesonide HFA pMDI 80 µg x 2 Actuations Twice Daily
